CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV)

CUSIP: 18914F103

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class
Equity / Common Stock
Shares outstanding
416,598,522
Total 13F shares
122,809,816
Share change
-1,185,159
Total reported value
$103,788,732
Put/Call ratio
57%
Price per share
$0.85
Number of holders
150
Value change
-$1,403,557
Number of buys
61
Number of sells
70

Quarterly Holders Quick Answers

What is CUSIP 18914F103?
CUSIP 18914F103 identifies CLOV - CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) as of Q1 2023

As of 31 Mar 2023, CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) was held by 150 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 122,809,816 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, PNC Financial Services Group, Inc., NORTHERN TRUST CORP, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, Voya Investment Management LLC, and JUPITER ASSET MANAGEMENT LTD. This page lists 152 institutional shareholders reporting positions in this security for the Q1 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.